Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
AfterNext HealthTech Acquisition Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/29/2021 |
8-K
| Quarterly results |
| 08/20/2021 |
8-K
| Quarterly results |
| 08/16/2021 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15 of the Securities Exchange Act of 1934 Date of Report : August 11, 2021 AfterNext HealthTech Acquisition Corp. Cayman Islands 001-40737 98-159329 301 Commerce Street., Suite 3300 Fort Worth, Texas 76102 871-4000 Registrant's telephone number, including area code Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 ...",
"Underwriting Agreement by and among the Company, Goldman Sachs & Co. LLC, Deutsche Bank Securities Inc. and BofA Securities, Inc., as representatives of the several underwriters named therein",
"Amended and Restated Memorandum and Articles of Association",
"Warrant Agreement between Continental Stock Transfer & Trust Company and the Company",
"Letter Agreement among the Company, the Sponsor and the Company's officers and directors",
"Investment Management Trust Account Agreement between Continental Stock Transfer & Trust Company and the Company",
"Registration Rights Agreement among the Company, the Sponsor and the other holders party thereto",
"Private Placement Warrants Purchase Agreement between the Company and the Sponsor",
"AfterNext HealthTech Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering",
"AfterNext HealthTech Acquisition Corp. Announces Closing of $250 Million Initial Public Offering" |
|
|
|